459 related articles for article (PubMed ID: 8387988)
1. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS
Int J Radiat Oncol Biol Phys; 1993 May; 26(2):239-44. PubMed ID: 8387988
[TBL] [Abstract][Full Text] [Related]
2. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
J Neurooncol; 1994; 21(2):177-85. PubMed ID: 7861194
[TBL] [Abstract][Full Text] [Related]
3. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.
Curran WJ; Scott CB; Horton J; Nelson JS; Weinstein AS; Nelson DF; Fischbach AJ; Chang CH; Rotman M; Asbell SO
J Neurooncol; 1992 Mar; 12(3):219-27. PubMed ID: 1583555
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
5. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
7. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
8. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
12. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.
Wisoff JH; Boyett JM; Berger MS; Brant C; Li H; Yates AJ; McGuire-Cullen P; Turski PA; Sutton LN; Allen JC; Packer RJ; Finlay JL
J Neurosurg; 1998 Jul; 89(1):52-9. PubMed ID: 9647172
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
14. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
Kowalczuk A; Macdonald RL; Amidei C; Dohrmann G; Erickson RK; Hekmatpanah J; Krauss S; Krishnasamy S; Masters G; Mullan SF; Mundt AJ; Sweeney P; Vokes EE; Weir BK; Wollman RL
Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
[TBL] [Abstract][Full Text] [Related]
15. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.
Kreth FW; Warnke PC; Scheremet R; Ostertag CB
J Neurosurg; 1993 May; 78(5):762-6. PubMed ID: 8385709
[TBL] [Abstract][Full Text] [Related]
17. Survival and functional status after resection of recurrent glioblastoma multiforme.
Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme.
Levin VA; Maor MH; Thall PF; Yung WK; Bruner J; Sawaya R; Kyritsis AP; Leeds N; Woo S; Rodriguez L
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):357-64. PubMed ID: 7673023
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme.
Gamburg ES; Regine WF; Patchell RA; Strottmann JM; Mohiuddin M; Young AB
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1359-62. PubMed ID: 11121634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]